Merck (MRK) Cash from Investing Activities (2009 - 2026)

Merck has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$10.2 billion for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 586.62% year-over-year to -$10.2 billion; the TTM figure through Mar 2026 stood at -$22.5 billion (down 186.35% YoY), while the FY2025 annual figure was -$13.7 billion, down 77.67% from the prior year.
• Cash from Investing Activities climbed to -$10.2 billion in Q1 2026, from -$11.2 billion in the prior quarter.
• Over the last five years, Cash from Investing Activities for MRK reached as high as $53.0 million in Q4 2023 and fell as low as -$11.4 billion in Q2 2023.
• The 5-year median for Cash from Investing Activities is -$1.4 billion (2024), against an average of -$3.0 billion.
• Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 103.03% — and 2024, when it tumbled 2824.53%.
• A 5-year view of Cash from Investing Activities shows it stood at -$1.7 billion in 2022, then surged by 103.03% to $53.0 million in 2023, then plunged by 2824.53% to -$1.4 billion in 2024, then tumbled by 675.69% to -$11.2 billion in 2025, then grew by 8.85% to -$10.2 billion in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$10.2 billion, -$11.2 billion, and -$283.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.